Myopia is a cause of sight loss reaching epidemic proportions around the globe. For most people with low to moderate myopia the main implications are refractive, but for those classed as having high myopia (-6.00DS or more) there is an increased risk of ocular pathology. For these patients, a number of possible interventions have been looked at, including the use of low-dose atropine. In this interview, Abeeda Khatoon speaks to Professor Niall Strang at Glasgow Caledonian University to find out how this intervention works and its availability in the UK.